Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadoxetate, disodium - injection, solution - 181.430mg - gadoxetate, disodium 181.430mg

Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - iopromide eqv iodine - injection - 623.40 mg - iopromide eqv iodine 300 mg/ml

Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - iopromide eqv iodine - injection - 768.86 mg - iopromide eqv iodine 370 mg/ml

Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadopentetic acid, dimeglumine salt - injection - 469 mg/ml - gadopentetic acid, dimeglumine salt 469 mg/ml

Evrópusambandið - enska - EMA (European Medicines Agency)

genzyme europe b.v. - alemtuzumab - leukemia, lymphocytic, chronic, b-cell - antineoplastic agents - mabcampath is indicated for the treatment of patients with b-cell chronic lymphocytic leukaemia (bcll) for whom fludarabine combination chemotherapy is not appropriate.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - estradiol valerate - oral tablet - 1mg

Ísrael - enska - Ministry of Health

bayer israel ltd - interferon beta 1b - powder and solvent for solution for injection - interferon beta 1b 0.3 mg/vial - interferon beta-1b - interferon beta-1b - use in ambulatory patients with relapsing-remitting multiple sclerosis (rrms) and relapsing progressive m.s. to reduce the frequency of clinical exacerbations. treatment of secondary progressive (sp) form of multiple sclerosis. treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of mri abnormalities characteristic of m.s. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.

Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadobutrol - injection - 604.720 mg - gadobutrol 604.720 mg

Singapúr - enska - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadobutrol - injection - 604.720 mg/ml(equiv. 1.0 mmol) - gadobutrol 604.720 mg/ml(equiv. 1.0 mmol)

Írland - enska - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - cyproterone acetate; ethinylestradiol - coated tablet - 2 mg/35 microgram(s) - cyproterone and estrogen